Realm Therapeutics plc American Depositary Shares
RLM
RLM was delisted on the 30th of July, 2019.
7 hedge funds and large institutions have $5.88M invested in Realm Therapeutics plc American Depositary Shares in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
13% less funds holding
Funds holding: 8 → 7 (-1)
39% less capital invested
Capital invested by funds: $9.64M → $5.88M (-$3.75M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$980K |
| 2 |
PC
Polar Capital
London,
United Kingdom
|
+$412K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$53.4K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$7.87K |
| 5 |
PSC
Piper Sandler & Co
Minneapolis,
Minnesota
|
+$2.02K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HSBC Holdings
London,
United Kingdom
|
-$1.7M |
| 2 |
A
Abingworth
London,
United Kingdom
|
-$988K |
| 3 |
FIA
FNY Investment Advisers
New York
|
-$138K |
| 4 |
IG
ING Group
Amsterdam,
Netherlands
|
-$116K |
RLM Hedge Fund Activity: Q2 2019 in Review
7 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Realm Therapeutics plc American Depositary Shares (RLM) for Q2 2019, worth a combined $5.88M — down 39% from $9.64M a quarter earlier.
Fund positioning in RLM was balanced in Q2 2019: 3 funds opened new positions, 3 closed out, 2 added to existing stakes and 1 trimmed.
The largest buyer was BVF Inc, adding an estimated $980K. The largest seller was HSBC Holdings, cutting an estimated $1.7M.
- 7 institutional investors held Realm Therapeutics plc American Depositary Shares (RLM) as of Q2 2019, down from 8 in Q1 2019.
- Funds reported $5.88M of Realm Therapeutics plc American Depositary Shares stock for Q2 2019, down 39% quarter-over-quarter.
- 3 funds opened new Realm Therapeutics plc American Depositary Shares positions in Q2 2019 and 3 closed out, a net change of 0 holders.
- The largest Realm Therapeutics plc American Depositary Shares buyer in Q2 2019 was BVF Inc, an estimated $980K added.
- The largest Realm Therapeutics plc American Depositary Shares seller in Q2 2019 was HSBC Holdings, an estimated $1.7M sold.
Based on aggregated 13F filings for Q2 2019.